 relationship prostate specific antigen levels residual tumor volume stage prostate cancer Preoperative serum prostate specific antigen correlates prostate tumor volume prostatectomy specimens prostate specific antigen hyperplastic malignant prostatic epithelium contribution hyperplastic epithelium benign prostatic hyperplasia prostate specific antigen interferes ability serum prostate specific antigen tumor volume individual patients removal benign prostatic hyperplasia tissue correlation prostate specific antigen tumor volume prostate specific accurate predictor residual cancer volume transurethral resection prostate total patients clinical stage cancer underwent radical retropubic prostatectomy stage stage disease pre-radical prostatectomy measurement serum prostate specific antigen morphometric determination residual cancer volume radical prostatectomy specimen correlation serum prostate specific antigen residual cancer volume patients stages stage cancer patients serum prostate specific antigen value ng./ml residual tumor volumes cc stage cancer patients serum prostate specific antigen value ng./ml residual tumor volumes cc patients levels ng./ml serum prostate specific antigen useful residual tumor volume group Serum prostate specific antigen measurements helpful stage cancer patients levels ng./ml ng./ml appropriate therapy